Developing treatments for rare diseases poses many unique challenges that cannot be addressed by traditional study designs. Small populations will result in prolonged enrolment periods and/or ...

“The decline in consecutive years might look small, but it’s an indicator that larger issues may lie under the surface.” That’s how Frank Hanley, senior director of auto benchmarking at J.D. Power, ...

Objective This study aimed to assess the prevalence of eye care service utilisation and associated factors among healthcare professionals in Gondar city, northwest Ethiopia. Design An ...

The next major challenge for artificial intelligence in drug development lies in proving its value in real-world settings. A new technology not only supports the generation of novel chemical entities ...